Elevated TLR2 and PGP9.5 levels in the gut epithelium suggested a connection between bacterial amyloids and neuroendocrine activation [98], highlighting a potential mechanism through which gut microbiota could influence AD pathology. This evidence concerns the gene TLR2 and Alzheimer disease.